Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

Background The relationship between immune related adverse events (irAEs) and efficacy is not definitively proven, and data on the relationship between irAE and treatment efficacy are contradictory. Material and methods Five hundred ninety-three consecutive patients with unresectable or metastatic m...

Full description

Bibliographic Details
Main Authors: Bożena Cybulska-Stopa, Marcin Ziętek, Anna M. Czarnecka, Karolina Piejko, Robert Dziura, Łukasz Galus, Barbara Ziółkowska, Stanisław Kieszko, Natasza Kempa-Kamińska, Jacek Calik, Joanna Seredyńska, Kamila Gądek, Tomasz Zemełka, Paweł Teterycz, Tomasz Kubiatowski, Rafał Suwiński, Jacek Mackiewicz, Piotr Rutkowski
Format: Article
Language:English
Published: Taylor & Francis Group 2022-05-01
Series:Journal of Dermatological Treatment
Subjects:
melanoma
irae
immunotherapy
anti-pd-1 therapy
immune-related adverse events
Online Access:http://dx.doi.org/10.1080/09546634.2021.1937477

Internet

http://dx.doi.org/10.1080/09546634.2021.1937477

Similar Items